Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


A Pharma Exec’s Inside View Of PCORI: Pfizer’s Freda Lewis-Hall

This article was originally published in The Pink Sheet Daily

Executive Summary

Pfizer Chief Medical Officer Freda Lewis-Hall, a member of the Patient-Centered Outcomes Research Institute’s Board of Governors, talked to “The Pink Sheet” DAILY about the institute’s work over the past two years and coming up in 2013 and how the institute and the pharmaceutical industry have interacted since PCORI was set up by the Affordable Care Act.

You may also be interested in...

Pfizer CMO Freda Lewis-Hall On The New R&D Shift: An Interview With PharmAsia News (Part 1 of 2)

A senior Pfizer executive pushes the theme of large collaborations by stakeholders globally to spur innovation and productivity.

PCORI Initiates A Targeted Approach To Research At November Meeting

In a departure from asking researchers to propose specific research topics within broadly defined areas, the board of the Patient-Centered Outcomes Research Institute approved a plan to fund research in three targeted areas – treatment of uterine fibroids, management of asthma in African-Americans and prevention of falls in the elderly – and up to two additional areas.

FDA 2015 Budget Increase Proposal Leans On Food Safety User Fees

Food safety programs would get the largest increase in the White House’s proposed fiscal 2015 FDA budget, and increases in user fee programs are proposed as key drivers for the boost. The agency’s overall budget would grow $335 million to $4.7 billion in the proposal.


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts